BCAP31
Basic information
Region (hg38): X:153700492-153724565
Links
Phenotypes
GenCC
Source:
- severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (Strong), mode of inheritance: XL
- severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (Strong), mode of inheritance: XL
- severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (Supportive), mode of inheritance: AR
- severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (Definitive), mode of inheritance: XL
- severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, dystonia, and cerebral hypomyelination | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Craniofacial; Neurologic | 24011989 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (4 variants)
- Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome (3 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCAP31 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 28 | 30 | ||||
missense | 51 | 58 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 3 | 7 | 1 | 11 | ||
non coding | 27 | 20 | 48 | |||
Total | 6 | 3 | 56 | 60 | 22 |
Variants in BCAP31
This is a list of pathogenic ClinVar variants found in the BCAP31 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-153700933-G-C | BCAP31-related disorder | Likely benign (Sep 17, 2024) | ||
X-153700939-A-G | Inborn genetic diseases | Likely pathogenic (Nov 09, 2017) | ||
X-153700941-TCTTC-T | Uncertain significance (Oct 01, 2018) | |||
X-153700945-C-T | Inborn genetic diseases | Uncertain significance (Jan 12, 2024) | ||
X-153700956-A-G | Uncertain significance (May 10, 2022) | |||
X-153700957-T-TG | Uncertain significance (Jun 08, 2022) | |||
X-153700959-G-A | Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 08, 2024) | ||
X-153700959-G-C | Uncertain significance (Jan 06, 2024) | |||
X-153700962-C-T | Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome | Uncertain significance (Jun 24, 2024) | ||
X-153700964-A-G | Likely benign (Mar 01, 2022) | |||
X-153700965-T-A | Microcephaly • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jun 23, 2023) | ||
X-153700969-C-G | Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome | Uncertain significance (Jul 28, 2020) | ||
X-153700972-C-T | Benign (Jan 06, 2025) | |||
X-153700974-G-A | Uncertain significance (Dec 16, 2024) | |||
X-153700975-C-T | BCAP31-related disorder | Uncertain significance (Dec 22, 2023) | ||
X-153700986-A-G | Uncertain significance (Jan 08, 2025) | |||
X-153701109-GC-G | Benign (Jul 05, 2018) | |||
X-153701993-A-G | Likely benign (May 06, 2024) | |||
X-153701994-C-T | Benign (Dec 02, 2024) | |||
X-153701995-G-A | Likely benign (Nov 05, 2024) | |||
X-153701999-G-A | Likely benign (Nov 16, 2022) | |||
X-153702019-G-A | Likely benign (Apr 25, 2024) | |||
X-153702033-A-C | Uncertain significance (Oct 22, 2024) | |||
X-153702036-G-A | Uncertain significance (Aug 08, 2024) | |||
X-153702039-C-T | Uncertain significance (Oct 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BCAP31 | protein_coding | protein_coding | ENST00000458587 | 8 | 24206 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.434 | 0.560 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.30 | 82 | 123 | 0.669 | 0.00000977 | 2024 |
Missense in Polyphen | 22 | 49.524 | 0.44423 | 768 | ||
Synonymous | 0.136 | 53 | 54.3 | 0.976 | 0.00000454 | 626 |
Loss of Function | 2.29 | 2 | 9.69 | 0.206 | 6.11e-7 | 189 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as a chaperone protein. Is one of the most abundant endoplasmic reticulum (ER) proteins. Plays a role in the export of secreted proteins in the ER, the recognition of abnormally folded protein and their targeting to the ER associated-degradation (ERAD). Also serves as a cargo receptor for the export of transmembrane proteins. May be involved in CASP8- mediated apoptosis. {ECO:0000269|PubMed:10958671, ECO:0000269|PubMed:18287538, ECO:0000269|PubMed:9396746}.;
- Disease
- DISEASE: Deafness, dystonia, and cerebral hypomyelination (DDCH) [MIM:300475]: An X-linked recessive mental retardation syndrome characterized by almost no psychomotor development, dysmorphic facial features, sensorineural deafness, dystonia, pyramidal signs, and hypomyelination on brain imaging. {ECO:0000269|PubMed:24011989}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=BCAP31 is deleted in the chromosome Xq28 deletion syndrome which involves BCAP31 and the and the promoter region of ABCD1. {ECO:0000269|PubMed:11992258}.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Apoptotic cleavage of cellular proteins;Apoptotic execution phase;Apoptosis;Programmed Cell Death
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.19
Haploinsufficiency Scores
- pHI
- 0.208
- hipred
- Y
- hipred_score
- 0.598
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bcap31
- Phenotype
Gene ontology
- Biological process
- antigen processing and presentation of peptide antigen via MHC class I;intracellular protein transport;endoplasmic reticulum to Golgi vesicle-mediated transport;apoptotic process;positive regulation of cytosolic calcium ion concentration;spermatogenesis;negative regulation of endoplasmic reticulum calcium ion concentration;calcium-mediated signaling using intracellular calcium source;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of mitochondrial calcium ion concentration;protein localization to endoplasmic reticulum exit site;positive regulation of ER-associated ubiquitin-dependent protein catabolic process;positive regulation of retrograde protein transport, ER to cytosol;positive regulation of intrinsic apoptotic signaling pathway
- Cellular component
- mitochondrion;endoplasmic reticulum;Sec61 translocon complex;endoplasmic reticulum membrane;lipid droplet;cytosol;integral component of plasma membrane;membrane;clathrin-coated vesicle;Golgi cisterna membrane;endoplasmic reticulum-Golgi intermediate compartment membrane;integral component of lumenal side of endoplasmic reticulum membrane;perinuclear endoplasmic reticulum
- Molecular function
- protein binding;MHC class I protein binding;protein-containing complex binding